Form 4 Jounce Therapeutics, For: May 03 Filed by: TANG CAPITAL PARTNERS LP May 5, 2023 04:38PM
Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP May 5, 2023 04:34PM
Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP Apr 7, 2023 04:00PM
Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP Mar 28, 2023 04:01PM
Jounce Therapeutics (JNCE) to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights Mar 27, 2023 09:01AM


Mar 27, 2023 09:00AM Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
Mar 17, 2023 04:01PM Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Mar 15, 2023 07:51AM Jounce Therapeutics (JNCE) Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Mar 14, 2023 09:00PM Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Mar 14, 2023 05:01PM Form SC 13D Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Mar 6, 2023 04:00PM Form SC 13G Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP